Would you offer pelvic nodal RT due to failure after previous pelvic node SBRT in oligorecurrent prostate cancer?

If so, are you worried about toxicity from overlap of treatments?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

In platinum-refractory or multiply-relapsed NSGCT with 1–2 progressive sites and no good surgical option, is there a role for local radiotherapy (e.g., SBRT) to those sites?

Would you continue serial PSMA PET scans after 2 negative scans for patients with a persistently rising PSA post-RT?

Are there any scenarios in which you would offer SBRT as your preferred treatment approach for appropriate candidates with intermediate risk prostate cancer?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.